Perspective Therapeutics
CATX
18 hedge funds and large institutions have $1.71M invested in Perspective Therapeutics in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and closing their positions.
281% more capital invested
Capital invested by funds: $448K → $1.71M (+$1.26M)
13% more funds holding
Funds holding: 16 → 18 (+2)
0.41% more ownership
Funds ownership: 0.27% → 0.68% (+0.41%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.04M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.3K |
| 3 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$12.5K |
| 4 |
Citigroup
New York
|
+$1.87K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$131 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAG
Crestwood Advisors Group
Boston,
Massachusetts
|
-$6.24K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$250 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$25 |
CATX Hedge Fund Activity: Q3 2013 in Review
18 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q3 2013, worth a combined $1.71M — up 281% from $448K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CATX positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.04M. The largest seller was Crestwood Advisors Group, cutting an estimated $6.24K.
- 18 institutional investors held Perspective Therapeutics (CATX) as of Q3 2013, up from 16 in Q2 2013.
- Funds reported $1.71M of Perspective Therapeutics stock for Q3 2013, up 281% quarter-over-quarter.
- 3 funds opened new Perspective Therapeutics positions in Q3 2013 and 0 closed out, a net change of +3 holders.
- The largest Perspective Therapeutics buyer in Q3 2013 was Sabby Management, an estimated $1.04M added.
- The largest Perspective Therapeutics seller in Q3 2013 was Crestwood Advisors Group, an estimated $6.24K sold.
Based on aggregated 13F filings for Q3 2013.